LDL electronegativity index: a potential novel index for predicting cardiovascular disease

References

• KraussRMLipoprotein subfractions and cardiovascular disease riskCurr Opin Lipidol20102130531120531184
   PubMed Web of Science ®Google Scholar
• MillsEJRachlisBWuPPrimary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patientsJ Am Coll Cardiol2008521769178119022156
   PubMed Web of Science ®Google Scholar
• GoffDCJrLloyd-JonesDMBennettG2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol2014632935295924239921
   PubMed Web of Science ®Google Scholar
• BaigentCKeechAKearneyPMEfficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statinsLancet20053661267127816214597
   PubMed Web of Science ®Google Scholar
• AfilaloJMajdanAAEisenbergMJIntensive statin therapy in acute coronary syndromes and stable coronary heart disease: a comparative meta-analysis of randomised controlled trialsHeart20079391492117277349
   PubMed Web of Science ®Google Scholar
• KjekshusJApetreiEBarriosVRosuvastatin in older patients with systolic heart failureN Engl J Med20073572248226117984166
   PubMed Web of Science ®Google Scholar
• GissiHFITavazziLMaggioniAPEffect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialLancet20083721231123918757089
   PubMed Web of Science ®Google Scholar
• BerneisKKKraussRMMetabolic origins and clinical significance of LDL heterogeneityJ Lipid Res2002431363137912235168
   PubMed Web of Science ®Google Scholar
• MelloAPda SilvaITAbdallaDSElectronegative low-density lipoprotein: origin and impact on health and diseaseAtherosclerosis201121525726521292266
   PubMed Web of Science ®Google Scholar
• RizzoMBerneisKLow-density lipoprotein size and cardiovascular risk assessmentQJM20069911416371404
   PubMed Web of Science ®Google Scholar
• PackardCCaslakeMShepherdJThe role of small, dense low density lipoprotein (LDL): a new lookInt J Cardiol200074Suppl 1S17S2210856769
   PubMedGoogle Scholar
• PackardCJSmall dense low-density lipoprotein and its role as an independent predictor of cardiovascular diseaseCurr Opin Lipidol20061741241716832165
   PubMed Web of Science ®Google Scholar
• GriffinBACaslakeMJYipBRapid isolation of low density lipoprotein (LDL) subfractions from plasma by density gradient ultracentrifugationAtherosclerosis19908359672390137
   PubMed Web of Science ®Google Scholar
• GriffinBAFreemanDJTaitGWRole of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease riskAtherosclerosis19941062412538060384
   PubMed Web of Science ®Google Scholar
• YeeMSPavittDVTanTLipoprotein separation in a novel iodixanol density gradient, for composition, density, and phenotype analysisJ Lipid Res2008491364137118337616
   PubMed Web of Science ®Google Scholar
• EnsignWHillNHewardCBDisparate LDL phenotypic classification among 4 different methods assessing LDL particle characteristicsClin Chem2006521722172716740651
   PubMed Web of Science ®Google Scholar
• OtvosJDJeyarajahEJBennettDWDevelopment of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurementClin Chem199238163216381326420
   PubMed Web of Science ®Google Scholar
• HiranoTItoYSaegusaHA novel and simple method for quantification of small, dense LDLJ Lipid Res2003442193220112897184
   PubMed Web of Science ®Google Scholar
• ItoYFujimuraMOhtaMDevelopment of a homogeneous assay for measurement of small dense LDL cholesterolClin Chem201157576521051530
   PubMed Web of Science ®Google Scholar
• AlbersJJKennedyHMarcovinaSMEvaluation of a new homogenous method for detection of small dense LDL cholesterol: comparison with the LDL cholesterol profile obtained by density gradient ultracentrifugationClin Chim Acta201141255656121156166
   PubMed Web of Science ®Google Scholar
• O’NealDHarripPDragicevicGA comparison of LDL size determination using gradient gel electrophoresis and light-scattering methodsJ Lipid Res199839208620909788255
   PubMed Web of Science ®Google Scholar
• WitteDRTaskinenMRPerttunen-NioHStudy of agreement between LDL size as measured by nuclear magnetic resonance and gradient gel electrophoresisJ Lipid Res2004451069107614993238
   PubMed Web of Science ®Google Scholar
• DiffenderferMRSchaeferEJThe composition and metabolism of large and small LDLCurr Opin Lipidol20142522122624811298
   PubMed Web of Science ®Google Scholar
• HirayamaSMiidaTSmall dense LDL: an emerging risk factor for cardiovascular diseaseClin Chim Acta201241421522422989852
   PubMed Web of Science ®Google Scholar
• SteinbergDParthasarathySCarewTEBeyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicityN Engl J Med19893209159242648148
   PubMed Web of Science ®Google Scholar
• JaakkolaOSolakiviTTertovVVCharacteristics of low-density lipoprotein subfractions from patients with coronary artery diseaseCoron Artery Dis199343793858261211
   PubMed Web of Science ®Google Scholar
• TertovVVBittolo-BonGSobeninIANaturally occurring modified low density lipoproteins are similar if not identical: more electronegative and desialylated lipoprotein subfractionsExp Mol Pathol1995621661728612720
   PubMed Web of Science ®Google Scholar
• SteinbergDWitztumJLOxidized low-density lipoprotein and atherosclerosisArterioscler Thromb Vasc Biol2010302311231621084697
   PubMed Web of Science ®Google Scholar
• MillerYIChoiSHWiesnerPOxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunityCirc Res201110823524821252151
   PubMed Web of Science ®Google Scholar
• PentikainenMOOorniKAla-KorpelaMModified LDL – trigger of atherosclerosis and inflammation in the arterial intimaJ Intern Med200024735937010762453
   PubMed Web of Science ®Google Scholar
• PalinskiWHorkkoSMillerECloning of monoclonal autoan-tibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasmaJ Clin Invest1996988008148698873
   PubMed Web of Science ®Google Scholar
• ItabeHYamamotoHImanakaTSensitive detection of oxidatively modified low density lipoprotein using a monoclonal antibodyJ Lipid Res19963745538820101
   PubMed Web of Science ®Google Scholar
• TertovVVSobeninIAOrekhovANModified (desialylated) low-density lipoprotein measured in serum by lectin-sorbent assayClin Chem199541101810217600681
   PubMed Web of Science ®Google Scholar
• OrekhovANTertovVVMukhinDNDesialylated low density lipoprotein – naturally occurring modified lipoprotein with atherogenic potencyAtherosclerosis1991861531611872910
   PubMed Web of Science ®Google Scholar
• TertovVVKaplunVVSobeninIAHuman plasma trans-sialidase causes atherogenic modification of low density lipoproteinAtherosclerosis200115910311511689212
   PubMed Web of Science ®Google Scholar
• YounisNCharlton-MenysVSharmaRGlycation of LDL in non-diabetic people: small dense LDL is preferentially glycated both in vivo and in vitroAtherosclerosis200920216216818511055
   PubMed Web of Science ®Google Scholar
• SoranHDurringtonPNSusceptibility of LDL and its subfractions to glycationCurr Opin Lipidol20112225426121734572
   PubMed Web of Science ®Google Scholar
• HoffHFGaubatzJWIsolation, purification, and characterization of a lipoprotein containing Apo B from the human aortaAtherosclerosis1982422732977073805
   PubMed Web of Science ®Google Scholar
• AvogaroPBonGBCazzolatoGPresence of a modified low density lipoprotein in humansArteriosclerosis1988879873341993
   PubMedGoogle Scholar
• Sanchez-QuesadaJLPerezACaixasAEffect of glycemic optimization on electronegative low-density lipoprotein in diabetes: relation to nonenzymatic glycosylation and oxidative modificationJ Clin Endocrinol Metabol20018632433249
   PubMed Web of Science ®Google Scholar
• GriffinBALipoprotein atherogenicity: an overview of current mechanismsProc Nutr Soc19995816316910343354
   PubMed Web of Science ®Google Scholar
• MatsuiHOkumuraKTokiYLow-density lipoprotein particle size as an independent predictor of glycated low-density lipoprotein levelDiabetes Care1999221220122110388998
   PubMed Web of Science ®Google Scholar
• La BelleMKraussRMDifferences in carbohydrate content of low density lipoproteins associated with low density lipoprotein subclass patternsJ Lipid Res199031157715882246611
   PubMed Web of Science ®Google Scholar
• TribbleDLRizzoMChaitAEnhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteinsAm J Med200111010311011165551
   PubMed Web of Science ®Google Scholar
• HasegawaGKajiyamaSTanakaTThe alpha-glucosidase inhibitor acarbose reduces the net electronegative charge of low-density lipoprotein in patients with newly diagnosed type 2 diabetesClin Chim Acta200839011011418230353
   PubMed Web of Science ®Google Scholar
• TertovVVSobeninIAOrekhovANSimilarity between naturally occurring modified desialylated, electronegative and aortic low density lipoproteinFree Radic Res1996253133198889495
   PubMed Web of Science ®Google Scholar
• Sanchez-QuesadaJLBenitezSOtalCDensity distribution of electronegative LDL in normolipemic and hyperlipemic subjectsJ Lipid Res20024369970511971940
   PubMed Web of Science ®Google Scholar
• GrecoGBaloghGBrunelliRGeneration in human plasma of misfolded, aggregation-prone electronegative low density lipoproteinBiophys J20099762863519619478
   PubMed Web of Science ®Google Scholar
• ChenCHJiangTYangJHLow-density lipoprotein in hypercho-lesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcriptionCirculation20031072102210812695302
   PubMed Web of Science ®Google Scholar
• YangCYRayaJLChenHHIsolation, characterization, and functional assessment of oxidatively modified subfractions of circulating low-density lipoproteinsArterioscler Thromb Vasc Biol2003231083109012689919
   PubMed Web of Science ®Google Scholar
• TangDLuJWalterscheidJPElectronegative LDL circulating in smokers impairs endothelial progenitor cell differentiation by inhibiting Akt phosphorylation via LOX-1J Lipid Res200849334717909223
   PubMed Web of Science ®Google Scholar
• ChanHCKeLYChuCSHighly electronegative LDL from patients with ST-elevation myocardial infarction triggers platelet activation and aggregationBlood20131223632364124030386
   PubMed Web of Science ®Google Scholar
• ChangPYChenYJChangFHAspirin protects human coronary artery endothelial cells against atherogenic electronegative LDL via an epigenetic mechanism: a novel cytoprotective role of aspirin in acute myocardial infarctionCardiovasc Res20139913714523519265
   PubMed Web of Science ®Google Scholar
• SchmitzGMollersCRichterVAnalytical capillary isotachophoresis of human serum lipoproteinsElectrophoresis199718180718139372273
   PubMed Web of Science ®Google Scholar
• ZhangBKaneshiTOhtaTRelation between insulin resistance and fast-migrating LDL subfraction as characterized by capillary isotachophoresisJ Lipid Res2005462265227716061945
   PubMed Web of Science ®Google Scholar
• DamascenoNRSevanianAApolinarioEDetection of electronegative low density lipoprotein (LDL-) in plasma and atherosclerotic lesions by monoclonal antibody-based immunoassaysClin Biochem200639283816310760
   PubMed Web of Science ®Google Scholar
• Santo Faulin TdoEde SenaKCRodrigues TellesAEValidation of a novel ELISA for measurement of electronegative low-density lipoproteinClin Chem Lab Med2008461769177519055454
   PubMed Web of Science ®Google Scholar
• Faulin TdoEde Sena-EvangelistaKCPachecoDBDevelopment of immunoassays for anti-electronegative LDL autoantibodies and immune complexesClin Chim Acta201241329129722037508
   PubMed Web of Science ®Google Scholar
• ParasassiTDe SpiritoMMeiGLow density lipoprotein misfolding and amyloidogenesisFASEB J2008222350235618292214
   PubMed Web of Science ®Google Scholar
• OorniKPentikainenMOAla-KorpelaMAggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactionsJ Lipid Res2000411703171411060340
   PubMed Web of Science ®Google Scholar
• BancellsCBenitezSJauhiainenMHigh binding affinity of electronegative LDL to human aortic proteoglycans depends on its aggregation levelJ Lipid Res20095044645518952981
   PubMed Web of Science ®Google Scholar
• BancellsCBenitezSOrdonez-LlanosJImmunochemical analysis of the electronegative LDL subfraction shows that abnormal N-terminal apolipoprotein B conformation is involved in increased binding to proteoglycansJ Biol Chem20112861125113321078674
   PubMed Web of Science ®Google Scholar
• BorenJOlinKLeeIIdentification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor bindingJ Clin Invest1998101265826649637699
   PubMed Web of Science ®Google Scholar
• Sanchez-QuesadaJLVillegasSOrdonez-LlanosJElectronegative low-density lipoprotein. A link between apolipoprotein B misfolding, lipoprotein aggregation and proteoglycan bindingCurr Opin Lipidol20122347948622964994
   PubMed Web of Science ®Google Scholar
• KeLYEnglerDALuJChemical composition-oriented receptor selectivity of L5, a naturally occurring atherogenic low-density lipoproteinPure Appl Chem2011839
   PubMed Web of Science ®Google Scholar
• UrsiniFDaviesKJMaiorinoMAtherosclerosis: another protein misfolding disease?Trends Mol Med2002837037412127722
   PubMed Web of Science ®Google Scholar
• AsatryanLHamiltonRTIsasJMLDL phospholipid hydrolysis produces modified electronegative particles with an unfolded apoB-100 proteinJ Lipid Res20054611512215489541
   PubMed Web of Science ®Google Scholar
• ParasassiTBittolo-BonGBrunelliRLoss of apoB-100 secondary structure and conformation in hydroperoxide rich, electronegative LDL(–)Free Radic Biol Med200131828911425493
   PubMed Web of Science ®Google Scholar
• BlancoFJVillegasSBenitezS2D-NMR reveals different populations of exposed lysine residues in the apoB-100 protein of electronegative and electropositive fractions of LDL particlesJ Lipid Res2010511560156520110441
   PubMed Web of Science ®Google Scholar
• BrunelliRBaloghGCostaGEstradiol binding prevents ApoB-100 misfolding in electronegative LDL(–)Biochemistry2010497297730220669963
   PubMed Web of Science ®Google Scholar
• BenitezSSanchez-QuesadaJLLuceroLChanges in low-density lipoprotein electronegativity and oxidizability after aerobic exercise are related to the increase in associated non-esterified fatty acidsAtherosclerosis200216022323211755941
   PubMed Web of Science ®Google Scholar
• GaubatzJWGillardBKMasseyJBDynamics of dense electronegative low density lipoproteins and their preferential association with lipoprotein phospholipase A(2)J Lipid Res20074834835717102149
   PubMed Web of Science ®Google Scholar
• JayaramanSGantzDLGurskyOEffects of phospholipase A(2) and its products on structural stability of human LDL: relevance to formation of LDL-derived lipid dropletsJ Lipid Res20115254955721220788
   PubMed Web of Science ®Google Scholar
• BenitezSSanchez-QuesadaJLRibasVPlatelet-activating factor acetylhydrolase is mainly associated with electronegative low-density lipoprotein subfractionCirculation2003108929612821559
   PubMed Web of Science ®Google Scholar
• HolopainenJMMedinaOPMetsoAJSphingomyelinase activity associated with human plasma low density lipoproteinJ Biol Chem2000275164841648910828058
   PubMed Web of Science ®Google Scholar
• KinnunenPKHolopainenJMSphingomyelinase activity of LDL: a link between atherosclerosis, ceramide, and apoptosis?Trends Cardiovasc Med200212374211796243
   PubMed Web of Science ®Google Scholar
• BancellsCCanalsFBenitezSProteomic analysis of electronegative low-density lipoproteinJ Lipid Res2010513508351520699421
   PubMed Web of Science ®Google Scholar
• WyattARWilsonMRIdentification of human plasma proteins as major clients for the extracellular chaperone clusterinJ Biol Chem20102853532353919996109
   PubMed Web of Science ®Google Scholar
• BenitezSVillegasVBancellsCImpaired binding affinity of electronegative low-density lipoprotein (LDL) to the LDL receptor is related to nonesterified fatty acids and lysophosphatidylcholine contentBiochemistry200443158631587215595841
   PubMed Web of Science ®Google Scholar
• UrataJIkedaSKogaSNegatively charged low-density lipoprotein is associated with atherogenic risk in hypertensive patientsHeart Vessels20122723524221491122
   PubMed Web of Science ®Google Scholar
• LuJYangJHBurnsARMediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosisCirc Res200910461962719150883
   PubMed Web of Science ®Google Scholar
• ChuCSWangYCLuLSElectronegative low-density lipoprotein increases C-reactive protein expression in vascular endothelial cells through the LOX-1 receptorPloS One20138e7053323950953
   PubMed Web of Science ®Google Scholar
• SobeninIASalonenJTZhelankinAVLow density lipoprotein-containing circulating immune complexes: role in atherosclerosis and diagnostic valueBioMed Res Int2014201420569725054132
   PubMed Web of Science ®Google Scholar
• Sanchez-QuesadaJLCamachoMAntonRElectronegative LDL of FH subjects: chemical characterization and induction of chemokine release from human endothelial cellsAtherosclerosis200316626127012535738
   PubMed Web of Science ®Google Scholar
• BenitezSCamachoMBancellsCWide proinflammatory effect of electronegative low-density lipoprotein on human endothelial cells assayed by a protein arrayBiochim Biophys Acta200617611014102116753331
   PubMed Web of Science ®Google Scholar
• EstruchMBancellsCBelokiLCD14 and TLR4 mediate cytokine release promoted by electronegative LDL in monocytesAtherosclerosis201322935636223880187
   PubMed Web of Science ®Google Scholar
• EstruchMSanchez-QuesadaJLOrdonez-LlanosJCeramide-enriched LDL induces cytokine release through TLR4 and CD14 in monocytes. Similarities with electronegative LDLClin Invest Arterioscler201426131137
   PubMedGoogle Scholar
• EstruchMSanchez-QuesadaJLBelokiLThe induction of cytokine release in monocytes by electronegative low-density lipoprotein (LDL) is related to its higher ceramide content than native LDLInt J Mol Sci2013142601261623358250
   PubMed Web of Science ®Google Scholar
• LeeASChenWYChanHCGender disparity in LDL-induced cardiovascular damage and the protective role of estrogens against electronegative LDLCardiovasc Diabetol2014136424666525
   PubMed Web of Science ®Google Scholar
• HsuJFChouTCLuJLow-density lipoprotein electronegativity is a novel cardiometabolic risk factorPLoS One20149e10734025203525
   PubMed Web of Science ®Google Scholar
• PencinaMJD’AgostinoRBSrLarsonMGPredicting the 30-year risk of cardiovascular disease: the framingham heart studyCirculation20091193078308419506114
   PubMed Web of Science ®Google Scholar
• D’AgostinoRBSrVasanRSPencinaMJGeneral cardiovascular risk profile for use in primary care: the Framingham Heart StudyCirculation200811774375318212285
   PubMed Web of Science ®Google Scholar
• FraleyAETsimikasSClinical applications of circulating oxidized low-density lipoprotein biomarkers in cardiovascular diseaseCurr Opin Lipidol20061750250916960498
   PubMed Web of Science ®Google Scholar
• ChenWYChenFYLeeASSesamol reduces the atherogenicity of electronegative L5 LDL in vivo and in vitroJ Nat Prod20157822523325692815
   PubMed Web of Science ®Google Scholar
• PedrosaAMFaineLAGrossoDMElectronegative LDL induction of apoptosis in macrophages: involvement of Nrf2Biochim Biophys Acta2010180143043720005974
   PubMed Web of Science ®Google Scholar
• KazumaSMCavalcanteMFTellesAECloning and expression of an anti-LDL(–) single-chain variable fragment, and its inhibitory effect on experimental atherosclerosisMAbs2013576377523924793
   PubMed Web of Science ®Google Scholar